Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06475339 · ClinicalTrials.gov registry record · NA
Predicting Responses to Exhausting, Prolonged, And Repeated Exercise Demands (PREPARED) for Heat
A NA study of Hyperthermia and Fatigue; Heat, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06475339: Recruiting NA study of Hyperthermia and Fatigue; Heat, sponsored by State University of New York at Buffalo.
NCT06475339 is a NA study of Hyperthermia and Fatigue; Heat that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 24 participants, below the 48-participant average among 15 other Hyperthermia trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06475339, a NA study of Hyperthermia and Fatigue; Heat, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to identify a work/rest cycle that allows for faster mission completion needed in emergency situations, compared to current Army heat guidance, while mitigating heat strain and neuromuscular fatigue. This project will determine the trade-off between faster mission completion and risk of heat strain and physical performance decrements. Completion of this project will allow military leaders to make informed decisions by understanding the impact of their choices on the magnitude of physical performance decrements and expected heat casualties, setting up hot weather missions for success.
Primary Outcome
Maximum gastrointestinal temperature reached during the work protocol
Conditions Studied
Interventions
- OTHER 30/30 work/rest cycle
- OTHER 30/20 work/rest cycle
- OTHER 40/30 work/rest cycle
- OTHER 20/12 work/rest cycle
Study Locations (1)
New York
- Center for Research and Education in Special Environments - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT06475339 shows while recruiting
NCT06475339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 48-participant average among 15 other Hyperthermia trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Hyperthermia appearing as the primary indexed condition, and to 4 interventions - of which 30/30 work/rest cycle is the first listed.
NCT06475339 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06475339 about?
NCT06475339 is a clinical study titled "Predicting Responses to Exhausting, Prolonged, And Repeated Exercise Demands (PREPARED) for Heat". The overall goal of this project is to identify a work/rest cycle that allows for faster mission completion needed in emergency situations, compared to current Army heat guidance, while mitigating heat strain and neuromuscular fatigue. This project will determine the trade-off between faster mission...
What is the current status of trial NCT06475339?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-11-01. Estimated completion is 2027-03.
What conditions does trial NCT06475339 study?
This clinical trial studies the following conditions: Hyperthermia, Fatigue; Heat.
What interventions are being tested in trial NCT06475339?
The interventions under investigation include: 30/30 work/rest cycle (OTHER), 30/20 work/rest cycle (OTHER), 40/30 work/rest cycle (OTHER), 20/12 work/rest cycle (OTHER).
Who is sponsoring clinical trial NCT06475339?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06475339 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperthermia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06475339's enrollment target sits among peer trials
24 7th of 15 higher than 7 of 15 other Hyperthermia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperthermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Heat Waves and the Elderly - Cooling Modalities
RECRUITING · NA
-
IEEM-Heat and Heart Failure
RECRUITING · NA
-
The Effectiveness of Emergency Room Protocols for Treating Hyperthermia
RECRUITING · NA
-
Skin Surface and Intradermal Temperature Responses to Heat Stress
ACTIVE NOT RECRUITING · NA
-
Renal Considerations in the Heat Stress Recommendations (Aim2)
COMPLETED · NA
-
Military Alerting System for Monitoring Body Temperature During Active Cooling
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI